HC Wainwright Issues Pessimistic Estimate for TRDA Earnings
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Entrada Therapeutics in a research note issued to investors on Monday, March 31st. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.92) per share for the quarter, down from their […]
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – Analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Entrada Therapeutics in a research note issued to investors on Monday, March 31st. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.92) per share for the quarter, down from their […]